Lacrimal Diversion Devices (Sinopsys Lacrimal Stent): Sharing our Experience with Patients with Chronic Rhinosinusitis without Polyposis

Abstract

Introduction Chronic rhinosinusitis (CRS) is a highly prevalent pathology in our society. Due to the prevalence of this condition and to the persisting symptoms despite an appropriate medical treatment, surgical techniques are often required. Lately, minimal invasive techniques have been described, such as lacrimal diversion devices (LDDs). This technique offers a fast and convenient choice for delivery of sinus irrigation and topical medication.

Objective We aimed to describe our experience with LDDs and evaluate the safety and effectiveness of the procedure in patients with moderate to severe CRS without nasal polyposis (CRSsNP) and persistent symptomatology despite medical therapy.

Methods A total of 7 patients underwent bilateral lacrimal stents placement in the operating room. A retrospective observational study was conducted. The Sino-Nasal Outcome Test-20 (SNOT-20) survey was performed and the score obtained was compared before and 1 month after the procedure.

Results The LDDs were used for an average of 80 days. During the follow-up, only three patients had a mild complication with the device (granuloma in the punctum, obstruction, and early extrusion). The mean baseline SNOT-20 score dropped significantly (p = 0.015) from 25.85 to 11.57 (mean: - 14.29) 1 month after the procedure.

Conclusion According to our experience and results, the use of LDD is a novel, feasible, and less invasive technique to treat refractory CRS. It reduces the risk of mucosal stripping, provides short-term outcomes, and the surgical procedure does not require advanced training in endoscopic sinus surgery. Moreover, it can be performed in-office under local anesthesia or sedation.

Keywords

sinusitis - paranasal sinuses - nasolacrimal duct - minimally invasive surgical procedures - nasal surgical procedures - drug delivery systems

• References

• 1 A Fokkens WJ, Lund VJ, Mullol J. , et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012; (23) 1-298
• 2 Orlandi RR, Kingdom TT, Hwang PH. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary. Int Forum Allergy Rhinol 2016; 6 (Suppl. 01) S3-S21
• 3 Mace J, Michael YL, Carlson NE, Litvack JR, Smith TL. Effects of depression on quality of life improvement after endoscopic sinus surgery. Laryngoscope 2008; 118 (03) 528-534
• 4 Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 2011; 120 (07) 423-427
• 5 Senior BA, Kennedy DW, Tanabodee J, Kroger H, Hassab M, Lanza D. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108 (02) 151-157
• 6 Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg 2008; 139 (01) 137-142
• 7 Catalano PJ, Strouch M. The minimally invasive sinus technique: theory and practice. Otolaryngol Clin North Am 2004; 37 (02) 401-409 , viii.
• 8 Velasquez N, Thamboo A, Abuzeid WM, Nayak JV. Safe treatment of ethmoid sinusitis utilizing minimally invasive ethmoid punch sinusotomy in chronic rhinosinusitis without polyposis patients. Laryngoscope 2017; 127 (06) 1268-1275
• 9 Tajudeen BA, Gupta S, Willoughby B, Kennedy DW. Delivering irrigation to the anterior ethmoid region: evaluation of a lacrimal diversion device in a cadaver model. Int Forum Allergy Rhinol 2017; 7 (08) 794-800
• 10 Smith TL, Batra PS, Seiden AM, Hannley M. Evidence supporting endoscopic sinus surgery in the management of adult chronic rhinosinusitis: a systematic review. Am J Rhinol 2005; 19 (06) 537-543
• 11 Hauser LJ, Turner JH, Chandra RK. Trends in the Use of Stents and Drug-Eluting Stents in Sinus Surgery. Otolaryngol Clin North Am 2017; 50 (03) 565-571
• 12 Weber R, Mai R, Hosemann W, Draf W, Toffel P. The success of 6-month stenting in endonasal frontal sinus surgery. Ear Nose Throat J 2000; 79 (12) 930-932 , 934, 937–938 passim
• 13 Orlandi RR, Knight J. Prolonged stenting of the frontal sinus. Laryngoscope 2009; 119 (01) 190-192
• 14 Nayak JV, Thamboo A, Gall P, Kennedy DW. Evidence of symptomatic and radiographic improvement following conjunctivodacrocystosinusotomy (CDCS) with lacrimal diversion device (LDD) placement as a novel therapeutic platform for sinusitis. Poster session presented at: Combined Otolaryngology Spring Meeting. 2018 April 18–22; Maryland, USA
• 15 Ramakrishnan VR, Kingdom TT, Nayak JV, Hwang PH, Orlandi RR. Nationwide incidence of major complications in endoscopic sinus surgery. Int Forum Allergy Rhinol 2012; 2 (01) 34-39
• 16 Catalano P, Roffman E. Outcome in patients with chronic sinusitis after the minimally invasive sinus technique. Am J Rhinol 2003; 17 (01) 17-22
• 17 Cutler J, Bikhazi N, Light J, Truitt T, Schwartz M. ; REMODEL Study Investigators. Standalone balloon dilation versus sinus surgery for chronic rhinosinusitis: a prospective, multicenter, randomized, controlled trial. Am J Rhinol Allergy 2013; 27 (05) 416-422